[1] | Ayano G (2016). Bipolar Disorder: A Concise Overview of Etiology, Epidemiology Diagnosis and Management: Review of Literatures. SOJ Psychol, 3(1):1-8. |
|
[2] | Goodwin FK, Jameson KR (2007). Manic-depressive illness: bipolar disorders and recurrent depression. Oxford University Press, Oxford, New York. Pp 231-237. |
|
[3] | Charles L. Bowden (2008). Bipolar Pathophysiology and Development of Improved Treatments, 1235: 92-97. |
|
[4] | Ressler KJ, Nemeroff CB (1999) Role of norepinefrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry. 46(9): 1219-33. |
|
[5] | Brunello N, Tascedda F (2003). Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol. 6(2): 18190. |
|
[6] | Kapczinski F, Freya BN, Zannattoa V (2004). Physiopathology of bipolar disorders: what has changed in the last 10 years? Rev Bras Psiquiatr. 26(Supl III):17-21. |
|
[7] | Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA (2013). Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 47(4): 32132. |
|
[8] | McCormick U, Murray B, McNew B (2015). Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. JAA of Nurse Practitioners 27530- 542. |
|
[9] | Brunello N, Tascedda F. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol. 2003; 6(2):181-189. |
|
[10] | Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA,. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. |
|
[11] | Axelson D, Goldstein B, Goldstein T, Monk K, Yu H, Hickey MB, Diagnostic Precursors to Bipolar Disorder in Offspring of Parents With Bipolar Disorder: A Longitudinal Study. Am J Psychiatry. 2015; 172(7): 638-646. |
|
[12] | The Columbia Bipolar Genetic Study. Bipolar disorder and genetics. Available at http://bipolar.hs.columbia.edu/disgenet.htm. Accessed: 2013, March 13. |
|
[13] | Ayano G. Bipolar Disorder: A Concise Overview of Etiology, Epidemiology Diagnosis and Management: Review of Literatures. SOJ Psychol 2016:3(1), 1-8. |
|
[14] | Ambelas A. Life events and mania: A special relationship. British Journal of Psychiatry. 1987; 150(2): 235-240. |
|
[15] | Yapici Eser H, Kacar AS, Kilciksiz CM, Yalçinay-Inan M, Ongur D. Prevalence and associated features of anxiety disorder comorbidity in bipolar disorder: a meta-analysis and meta-regression study. Front Psychiatry 2018; 9: 229. |
|
[16] | Onyeka IN, Collier Høegh M, Nåheim Eien EM, Nwaru BI, Melle I. Comorbidity of physical disorders among patients with severe mental illness with and without substance use disorders: a systematic review and meta-analysis. J Dual Diagn 2019; 15: 192-206. |
|
[17] | McElroy SL, Winham SJ, Cuellar-Barboza AB,. Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8. Transl Psychiatry 2018; 8: 40. |
|
[18] | McIntyre RS, Correll C. Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach. Bipolar Disord 2014; 16: 451-54. |
|
[19] | Coello K, Kjærstad HL, Stanislaus S. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Aust N Z J Psychiatry 2019; 53: 651-62. |
|
[20] | Goldstein BI, Carnethon MR, Matthews KA,. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2015; 132: 965-86. |
|
[21] | Petri E, Bacci O, Barbuti M,. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study. Bipolar Disord 2017; 19: 458-64. |
|
[22] | Bora E, Yucel M, Fornito A, Berk M, Pantelis C. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers? Acta Psychiatr Scand 2008; 118: 172-87. |
|
[23] | Johansson V, Kuja-Halkola R, Cannon TD, Hultman CM, Hedman AM. A population-based heritability estimate of bipolar disorder—in a Swedish twin sample. Psychiatry Res 2019; 278: 180-87. |
|
[24] | Fabbri C. The role of genetics in bipolar disorder. Curr Top Behav Neurosci 2020; published online August 7. |
|
[25] | Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience 2009; 164: 331-43. |
|
[26] | Stahl EA, Breen G, Forstner AJ,. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet 2019; 51: 793-803. |
|
[27] | Chen DT, Jiang X, Akula N. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18: 195-205. |
|
[28] | Smeland OB,. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol Psychiatry 2020; 25: 844-53. |
|
[29] | Wang M, Zhang L, Gage FH. Modeling neuropsychiatric disorders using human induced pluripotent stem cells. Protein Cell 2020; 11: 45-59. |
|
[30] | Andreazza AC, Duong A, Young LT. Bipolar disorder as a mitochondrial disease. Biol Psychiatry 2018; 83: 720-21. |
|
[31] | Berk M, Kapczinski F, Andreazza AC,. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-17. |
|
[32] | Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 2014; 218: 61-68. |
|
[33] | Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009; 70: 1078-90. |
|
[34] | Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014; 53: 23-34. |
|
[35] | Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M. C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry 2015; 76: 142-150. |
|
[36] | Kieseppä T., Partonen T., Haukka J., Kaprio J., Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry 2004.161(10), 1814-1821. |
|
[37] | Kim YK, Hwang JA, Lee HJ, Yoon HK, Ko YH, Lee BH,. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder. J Affect Disord 2014, 158, 127-132. |
|
[38] | Kurita M, Nishino S, Numata Y, Okubo Y, Sato T. The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study. PLoS One 2014, 9(6), e100634. |
|
[39] | Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, De Berardi D, Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. J Affect Disord 2013. 151(2), 540-550. |
|
[40] | Ikeda M, Takahashi A, Kamatani Y, Okahisa Y, Kunugi H, Mori N,. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry 2018, 23(3), 639-647. |
|
[41] | Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J. A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 2002, 45(4), 182-185. |
|
[42] | Zill P., Engel R., Baghai TC, Juckel G., Frodl T., Müller-Siecheneder F (2002). Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology : 26(4), 489-493. |
|
[43] | Pilkington K, Kirkwood G, Rampes H, Richardson J (2005). Yoga for depression: the research evidence. J Affect Disord. 89: 13-24. |
|
[44] | Wood C (1993) Mood change and perceptions of vitality: a comparison of the effects of relaxation, visualization and yoga. J R Soc Med. 86:254-258. |
|
[45] | Kjærgaard M, Waterloo K, Wang CE, (2012). Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry. 201:360-368. |
|
[46] | Pan NL, Jiang MJ, Poon PWF, Huang AM (2006). The role of brain-derived neurotrophic factor in the antidepressant effects of Sudarshan Kriya Yoga. Master’s thesis. |
|